Navigation Links
AIUM releases second edition of 'Medical Ultrasound Safety'
Date:5/15/2009

LAUREL, MDThe American Institute of Ultrasound in Medicine is pleased to announce the release of Medical Ultrasound Safety, Second Edition. All operators of ultrasound systems with an output display should review the information in this publication. The book consists of 3 parts: Bioeffects and Biophysics, Prudent Use, and Implementing ALARA (as low as reasonably achievable). With the information from this 64 page publication, users can better control the diagnostic ultrasound equipment and examination to ensure that needed diagnostic information is obtained with minimal risk to the patient.

A new feature of this edition is the inclusion of a CME self-study test at the end of each section. Individuals who successfully complete all 3 self-study tests can earn up to 3 AMA PRA Category 1 Credits (accepted by the ARDMS) or ARRT Category A Credits. Fees for CME credits apply, and instructions for test submission are included within the publication.

Over 140,000 copies of the first edition have been sold since 1994, attesting to the popularity and critical nature of the publication. Marvin C. Ziskin, MD, Chairman of the Revision Task Force, states in the preface to the second edition that "Many technological advances in ultrasonic scanning have occurred since the publication of the first edition". Ziskin goes on to emphasize the importance of education and awareness in health care practice to ensure its safe and practical use:

"The improved instrumentation has fostered an ever-increasing range of clinical applications. Ultrasound imaging has become an integral part of virtually all areas of medicine. The number of ultrasound examinations has continually increased and is now in the millions each year. Along with this increased use there is a significant benefit to more patients, but at the same time more individuals are exposed to greater amounts of ultrasound energy. Furthermore, some new techniques, such as the introduction of contrast agents, significantly increase the risk of possible harmful effects from ultrasound examinations. Health care professionals need to be concerned that patients are not exposed to any unnecessary risk. The purpose of this manual is to help the health professional be aware of the potential harmful effects of ultrasound and how to minimize their occurrence."

The US Food and Drug Administration (FDA) Center for Devices and Radiological Health suggests to manufacturers that they provide a copy of Medical Ultrasound Safety with ultrasound equipment they sell. This publication meets the FDA recommendations (Track 3.4.1) for education programs for the clinical end-user. A licensing agreement for Medical Ultrasound Safety is available for manufacturers. Details on this opportunity may be obtained by contacting the AIUM fulfillment coordinator at 301-498-4100.


'/>"/>

Contact: Jennifer Hilderbrand
jhilderbrand@aium.org
301-498-4100
American Institute of Ultrasound in Medicine
Source:Eurekalert

Related medicine news :

1. Watson-Marlow Releases Informative Video Featuring Showcased High Purity Pumps, Tubing and Fillers at Interphex 2009
2. MessageSolution Releases Email & File Archive Enterprise Suite with SharePoint Archiving at Microsoft TechEd North America 2009
3. Stanford Center on Longevity Releases New Findings About Voter Attitudes on Health Care Reform
4. KLRI Releases 3rd Annual Report On Years Top Longevity Research Findings
5. DRE Medical Equipment Releases New Multi-Function Patient Monitors
6. MessageSolution Releases SaaS Hosted Archiving Solution at Microsoft TechEd North America 2009
7. American Scientific Resources, Inc. Releases First Quarter Revenues
8. Watchdog Group Releases Report Highlighting Sen. Nelsons Ties to Health and Insurance Industries
9. SCAI Releases Consensus Statement on Length of Stay Following Elective Percutaneous Coronary Intervention
10. VetCentric Releases Findings of Pet Owner Survey
11. Diatherix Laboratories Releases First Clinically Available Test For Confirmation of The Swine Flu Virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... ... services to communities in east Texas, is launching a regional charity effort to ... Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) has raised nearly $30 ...
(Date:8/18/2017)... Bedford, TX (PRWEB) , ... August 18, 2017 , ... ... serves communities in the Dallas/Fort Worth area, is spearheading a regional charity campaign organized ... her husband. , In early June of this year, Christina and her children returned ...
(Date:8/18/2017)... ... 2017 , ... Alcovit, a lime-flavored beverage that rids the body of toxins ... product now available through Jet.com. , After 25 years of development, the company ... designed to quickly detox the body thereby avoiding alcohol-induced hangovers. Whether you’re having fun ...
(Date:8/18/2017)... , ... August 18, 2017 , ... “Dangerous Inheritance”: a ... author, Diane Winters. Diane is from Southwest Nebraska where she was raised on ... and family. The story is fictional, but the friendships and mantra of ‘neighbors ...
(Date:8/18/2017)... ... August 18, 2017 , ... Rollon Skin ... anti-aging skincare solutions, recently announced the launch of two new skincare products, ... yet effective alternative to expensive plastic surgery or in-patient cosmetic dermatological procedures. , ...
Breaking Medicine News(10 mins):
(Date:8/4/2017)... -- Agragen, LLC, a Cincinnati -based ... and aquacultural feed sectors, announces a significant step ... AGR131.  This drug is designed to trap and ... patients suffering from inflammatory conditions such as rheumatoid ... Biological pharmaceuticals currently used ...
(Date:8/2/2017)...   Marshall County Hospital in Benton, Kentucky has added ... hospital-acquired infections (HAIs). The new addition, Tru-D SmartUVC , short for "total room ultraviolet ... such as C. diff , MRSA, MERS, Ebola and more. ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
(Date:8/1/2017)...   CerSci Therapeutics , a non-opioid drug development ... has received notice from the National Institute on Drug ... that it has been awarded a Direct-to-Phase II Small ... 2017 with an additional $1,000,000 to follow in 2018. ... of their lead non-opioid drug candidate CT-044 to the ...
Breaking Medicine Technology: